NASDAQ:SWAV
Delisted

Shockwave Medical Stock News

etoro logo Buy SWAV
*Your capital is at risk
$334.75
+0 (+0%)
At Close: Aug 29, 2024
Shockwave Medical (SWAV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

3 Pharma Stocks That Will Mint Millionaires

10:20am, Monday, 30'th Jan 2023
In recent weeks, the Street has become much more enamored with pharma stocks than it was previously. The iShares Biotechnology ETF (NASDAQ: IBB ) climbed 6% so far this year.
Mergers and acquisitions are a normal part of business, but 2023 has already presented many opportunities across the biotech industry. The M&A surge seems to be driven by two major transactions: the $
ShockWave Medical's (SWAV) revenue growth in the fourth quarter is likely to have been boosted by continued strength in its U.S. Coronary business.
Shockwave Medical's (SWAV) latest acquisition is expected to serve a wider patient pool.

Shockwave Medical To Buy Neovasc: Details (NVCN)

09:33am, Wednesday, 18'th Jan 2023
Neovasc announced that it is being acquired by Shockwave Medical. These are the details.
Shockwave Medical (SWAV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Investors need to pay close attention to ShockWave Medical (SWAV) stock based on the movements in the options market lately.
The best retirement stocks for investors over 50 have reliability in common. Retirement stocks come in a few flavors, but the best retirement stocks for investors over 50 provide a mix of growth, stab
ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.
Investors who bought ShockWave Medical stock during the IPO in early 2019 have experienced a massive 570% share price growth. The company is gaining market share because it offers the best-in-class me
we have identified five non-technology Nasdaq stocks that have popped in 2022 despite the index's blood bath. These are: UTHR, LPLA, ENPH, SWAV, CHX.

2 Elite Growth Stocks Ready for a Bull Run in 2023

05:37am, Wednesday, 14'th Dec 2022
It's going to take more than a recession to stop these two from delivering outsized gains to patient investors.
Shockwave Medical (SWAV) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in
Shockwave Medical (SWAV) reported earnings 30 days ago. What's next for the stock?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE